Vnitr Lek 2026, 72(1):E15-E21 | DOI: 10.36290/vnl.2026.012

Neutrophil-lymphocyte ratio as a marker of increased cardiovascular risk in patients with moderate to severe hidradenitis suppurativa: prospective observational study

Tereza Neplechová1, Zlatica Žingorová1, Tomáš Bolek2, Matej Samoš2, Martin Jozef Péč2, Denis Hrivnák3, Karolína Vorčáková1
1 Dermatovenerologická klinika, Jesseniova lekárska fakulta v Martine Univerzity Komenského v Bratislave
2 1. interná klinika, Jesseniova lekárska fakulta v Martine Univerzity Komenského v Bratislav
3 Klinika stomatológie a maxilofaciálnej chirurgie, Jesseniova lekárska fakulta v Martine Univerzity Komenského v Bratislave, Univerzitná nemocnica Martin

Aim: Hidradenitis suppurativa (HS) is a pro-inflammatory condition associated with other comorbidities, such as obesity and an increased risk of cardiovascular (CV) disease. One of the prognostic markers of CV risk is the neutrophil-to-lymphocyte ratio (NLR), which is an inflammatory marker and a strong prognostic indicator for patients suffering from various diseases. The aim of this study was to confirm the increased cardiovascular risk in patients with moderate to severe HS based on an elevated NLR compared to a control group of healthy individuals.

Materials and methods: In this study, we prospectively monitored laboratory parameters in 51 patients with moderate to severe HS, whose disease severity was determined using the IHS4 scoring system. We compared the group with a control group of 51 healthy individuals. Peripheral venous blood was collected from all patients in both groups, and the NLR was determined from the absolute values of neutrophils and lymphocytes in the blood count. These results were then compared between the group of patients with HS and the control group of healthy individuals using a paired t-test, with a statistical significance threshold (α) set at 0,05.

Results: In descriptive statistics, the average number of neutrophils, lymphocytes, and NLR was higher in the examined group of patients with HS than in the control group of healthy individuals. Using a paired t-test, we demonstrated statistically significantly higher values for the averages of individual hematological markers monitored.

Conclusion: The results of the study show that patients with HS have higher NLR values than healthy individuals, which may be associated with an increased risk of CV and other complications. Our results highlight the presence of systemic inflammation in individuals with HS and suggest that these markers of inflammation may be valuable in clinical practice for screening and monitoring the progression of HS.

Keywords: hidradenitis suppurativa, systemic inflammation, cardiovascular risk, cardiovascular disease, neutrophil-to-lymphocyte ratio, inflammatory marker.

Accepted: February 5, 2026; Published: February 12, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Neplechová T, Žingorová Z, Bolek T, Samoš M, Péč MJ, Hrivnák D, Vorčáková K. Neutrophil-lymphocyte ratio as a marker of increased cardiovascular risk in patients with moderate to severe hidradenitis suppurativa: prospective observational study. Vnitr Lek. 2026;72(1):E15-21. doi: 10.36290/vnl.2026.012.
Download citation

References

  1. Ballard K, Shuman VL. Hidradenitis Suppurativa. StatPearls 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534867/.
  2. Krueger JG, Frew J, Jemec GBE, et al. Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape. Br J Dermatol 2024;190(2):e149-e162. Available from: https://academic.oup.com/bjd/article/190/2/149/7275339?login=false. Go to original source... Go to PubMed...
  3. González-López MA. Hidradenitis suppurativa. Med Clin (Barc) 2024;162(4):e182-e189. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534867/. Go to original source...
  4. Agnese ER, Tariche N, Sharma A, et al. The Pathogenesis and Treatment of Hidradenitis Suppurativa. Cureus 2023;15(11):e49390. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10749691/. Go to original source... Go to PubMed...
  5. Worapongsatitaya P, Chaikijurajai T, Ponvilawan B, et al. Hidradenitis Suppurativa and Risk of Coronary Artery Disease: A Systematic Review and Meta-Analysis. Indian J Dermatol. 2023;68(4):e359-365. Available from: https://pubmed.ncbi.nlm.nih.gov/37822371/. Go to original source... Go to PubMed...
  6. Li Y-H, Chuang S-H, Yang H-J. Systematic review and meta-analysis of peripheral blood inflammatory markers in hidradenitis Suppurativa. J Dermatol 2025;52:e583-e592. Available from: https://doi.org/10.1111/1346-8138.17661. Go to original source... Go to PubMed...
  7. Hessam S, Scholl L, Sand M, et al. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa. JAMA Dermatol 2018;154(3):e330-e335. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/2671025. Go to original source... Go to PubMed...
  8. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy 2021;122(7):e474-e488. Available from: https://www.elis.sk/index.php?page=shop.product_details & flypage=flypage.tpl & product_id=7271 & category_id=171 & option=com_virtuemart & vmcchk=1 & Itemid=1. Go to original source... Go to PubMed...
  9. Shen YH, Huang YC. Associations between the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio and hidradenitis suppurativa: a systematic review and meta-analysis. Arch Dermatol Res 2024;316(9):e628. Available from: https://link.springer.com/article/10.1007/s00403-024-03365-7. Go to original source... Go to PubMed...
  10. Chen X, Li A, Ma Q. Neutrophil-lymphocyte ratio and systemic immune-inflammation index as predictors of cardiovascular risk and mortality in prediabetes and diabetes: a population-based study. Inflammopharmacology 2024;32(5):e3213-e3227. Available from: https://pubmed.ncbi.nlm.nih.gov/39167310/. Go to original source... Go to PubMed...
  11. Li X, Liu M, Wang G. The neutrophil-lymphocyte ratio is associated with all-cause and cardiovascular mortality in cardiovascular patients. Sci Rep 2024;14(1):e26692. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11535400/. Go to original source... Go to PubMed...
  12. Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int J Mol Sci 2022;23(7):e3636. Available from: https://www.mdpi.com/1422-0067/23/7/3636. Go to original source... Go to PubMed...
  13. Öksüm Solak E, Baran Ketencioglu B, et al. The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa. Int J Dermatol 2023;62(8):e1076-e1081. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ijd.16744. Go to original source... Go to PubMed...
  14. Shah N, Parikh V, Patel N, et al. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol 2014;171(3):e390-e397. Available from: https://www.internationaljournalofcardiology.com/article/S0167-5273(13)02229-8/abstract. Go to original source... Go to PubMed...
  15. Krajewski PK, Matusiak Ł, Ständer S, et al. Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study. Int J Dermatol 2024;63(6):e799-e805. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ijd.17186. Go to original source... Go to PubMed...
  16. Verma SS, Sharma K, Chhabra S. Pathogenesis of Hidradenitis Suppurativa: An Immunological Perspective. Indian J Dermatol 2023;68(3):e296-e300. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10389144/. Go to original source... Go to PubMed...
  17. van Dalen SCM, Stein JWJ, Bruurmijn T, et al. Neutrophil Extracellular Traps Are Widely Distributed Across Lesional and Perilesional Hidradenitis Suppurativa Skin, and Elevated Serum NET Markers Associate With Moderate to Severe HS Disease. Int J Dermatol 2025;64(7):e1234-e1241. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12207707/. Go to original source... Go to PubMed...
  18. Yuan Y, Sun C, Liu X, et al. The Role of Neutrophil Extracellular Traps in Atherosclerosis: From the Molecular to the Clinical Level. J Inflamm Res 2025;18:e4421-e4433. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11955173/. Go to original source... Go to PubMed...
  19. Holgersen N, Nielsen VW, Rosenø NAL, et al. Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa. JAAD Int 2024;15:e170-e178. Available from: https://www.jaadinternational.org/article/S2666-3287(24)00039-7/fulltext. Go to original source... Go to PubMed...
  20. Kearney N, McCourt C, Hambly R, et al. Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio. JAMA Dermatol 2023;159(2):e222-e224. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/2799563. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.